These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 35758752)

  • 21. Characterization of carbapenem-resistant Pseudomonas aeruginosa clinical isolates, carrying multiple genes coding for this antibiotic resistance.
    Rizek C; Fu L; Dos Santos LC; Leite G; Ramos J; Rossi F; Guimaraes T; Levin AS; Costa SF
    Ann Clin Microbiol Antimicrob; 2014 Sep; 13():43. PubMed ID: 25179208
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterization of the new metallo-beta-lactamase VIM-13 and its integron-borne gene from a Pseudomonas aeruginosa clinical isolate in Spain.
    Juan C; Beceiro A; Gutiérrez O; Albertí S; Garau M; Pérez JL; Bou G; Oliver A
    Antimicrob Agents Chemother; 2008 Oct; 52(10):3589-96. PubMed ID: 18644957
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Carbapenemase -producing Pseudomonas aeruginosa isolates from Turkey: first report of P. aeruginosa high-risk clones with VIM-5- and IMP-7-type carbapenemases in a tertiary hospital.
    Çekin ZK; Dabos L; Malkoçoğlu G; Fortineau N; Bayraktar B; Iorga BI; Naas T; Aktaş E
    Diagn Microbiol Infect Dis; 2021 Jan; 99(1):115174. PubMed ID: 32980808
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Emergence of Imipenem-Resistant Pseudomonas aeruginosa Clinical Isolates from Egypt Coharboring VIM and IMP Carbapenemases.
    El-Domany RA; Emara M; El-Magd MA; Moustafa WH; Abdeltwab NM
    Microb Drug Resist; 2017 Sep; 23(6):682-686. PubMed ID: 28085553
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular epidemiology of carbapenem-resistant Pseudomonas aeruginosa in an endemic area: comparison with global data.
    Karampatakis T; Antachopoulos C; Tsakris A; Roilides E
    Eur J Clin Microbiol Infect Dis; 2018 Jul; 37(7):1211-1220. PubMed ID: 29644540
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Detection of carbapenem resistant Pseudomonas aeruginosa co-harboring blaVIM-2 and blaGES-5 in burn patients.
    Hmissi S; Raddaoui A; Frigui S; Abbassi MS; Achour W; Chebbi Y; Thabet L
    Acta Microbiol Immunol Hung; 2023 Sep; 70(3):199-205. PubMed ID: 37490366
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A highly carbapenem-resistant Pseudomonas aeruginosa isolate with a novel blaVIM-4/blaP1b integron overexpresses two efflux pumps and lacks OprD.
    Maniati M; Ikonomidis A; Mantzana P; Daponte A; Maniatis AN; Pournaras S
    J Antimicrob Chemother; 2007 Jul; 60(1):132-5. PubMed ID: 17483142
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Integron diversity in bla
    Savinova TA; Bocharova YA; Lazareva AV; Chebotar IV; Mayanskiy NA
    Klin Lab Diagn; 2019; 64(8):497-502. PubMed ID: 31479607
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification and genetic characterization of metallo-beta-lactamase-producing strains of Pseudomonas aeruginosa in Tehran, Iran.
    Shahcheraghi F; Nikbin VS; Feizabadi MM
    New Microbiol; 2010 Jul; 33(3):243-8. PubMed ID: 20954442
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Distribution of Pseudomonas-Derived Cephalosporinase and Metallo-β-Lactamases in Carbapenem-Resistant Pseudomonas aeruginosa Isolates from Korea.
    Cho HH; Kwon GC; Kim S; Koo SH
    J Microbiol Biotechnol; 2015 Jul; 25(7):1154-62. PubMed ID: 25907063
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Citrobacter freundii resistant to novel β-lactamase inhibitor combinations and cefiderocol, co-producing class A, B and D carbapenemases encoded by transferable plasmids.
    Riccobono E; Salvetti S; Coppi M; Montenora I; Di Pilato V; Rossolini GM
    J Antimicrob Chemother; 2023 Jul; 78(7):1677-1682. PubMed ID: 37207353
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular surveillance of carbapenemase-producing
    Schäfer E; Malecki M; Tellez-Castillo CJ; Pfennigwerth N; Marlinghaus L; Higgins PG; Mattner F; Wendel AF
    Antimicrob Resist Infect Control; 2019; 8():208. PubMed ID: 31893042
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Description of an original integron encompassing blaVIM-2, qnrVC1 and genes encoding bacterial group II intron proteins in Pseudomonas aeruginosa.
    Belotti PT; Thabet L; Laffargue A; André C; Coulange-Mayonnove L; Arpin C; Messadi A; M'Zali F; Quentin C; Dubois V
    J Antimicrob Chemother; 2015 Aug; 70(8):2237-40. PubMed ID: 25977399
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of a novel metallo-β-lactamase VIM-28 located within unusual arrangement of class 1 integron structure in Pseudomonas aeruginosa isolates from Egypt.
    El-Mahdy TS
    Jpn J Infect Dis; 2014; 67(5):382-4. PubMed ID: 25241690
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genotypes, carbapenemase carriage, integron diversity and oprD alterations among carbapenem-resistant Pseudomonas aeruginosa from Russia.
    Bocharova Y; Savinova T; Lazareva A; Polikarpova S; Gordinskaya N; Mayanskiy N; Chebotar I
    Int J Antimicrob Agents; 2020 Apr; 55(4):105899. PubMed ID: 31931151
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hospital outbreak of multiple clones of Pseudomonas aeruginosa carrying the unrelated metallo-beta-lactamase gene variants blaVIM-2 and blaVIM-4.
    Pournaras S; Maniati M; Petinaki E; Tzouvelekis LS; Tsakris A; Legakis NJ; Maniatis AN
    J Antimicrob Chemother; 2003 Jun; 51(6):1409-14. PubMed ID: 12716773
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A Novel VIM-Type Metallo-β-Lactamase Variant, VIM-60, with Increased Hydrolyzing Activity against Fourth-Generation Cephalosporins in Pseudomonas aeruginosa Clinical Isolates in Japan.
    Hishinuma T; Tada T; Uchida H; Shimojima M; Kirikae T
    Antimicrob Agents Chemother; 2019 Jun; 63(6):. PubMed ID: 30962328
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Whole Genome Sequencing of a
    Dziri R; Kuşkucu MA; Arfaoui A; Fethi M; Ifaoui S; Bellaaj R; Ouzari I; Saltoğlu N; Klibi N
    Microb Drug Resist; 2022 Jan; 28(1):18-22. PubMed ID: 34348037
    [No Abstract]   [Full Text] [Related]  

  • 39. Characterisation of VIM-2-producing Pseudomonas aeruginosa isolates from lower tract respiratory infections in a Spanish hospital.
    Bellés A; Bueno J; Rojo-Bezares B; Torres C; Javier Castillo F; Sáenz Y; Seral C
    Eur J Clin Microbiol Infect Dis; 2018 Oct; 37(10):1847-1856. PubMed ID: 29978304
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Full characterization of an IncR plasmid harboring qnrS1 recovered from a VIM-11-producing Pseudomonas aeruginosa.
    Elena A; Quinteros M; Di Conza J; Gutkind G; Cejas D; Radice MA
    Rev Argent Microbiol; 2020; 52(4):298-304. PubMed ID: 31983491
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.